Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

Report ID: 79165 | Published Date: Oct 2024 | No. of Page: 112 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1 Introduction	6
1.1 Industry Definition and Research Scope	6
1.1.1 Industry Definition	6
1.1.2 Research Scope	7
1.2 Research Methodology	10
1.2.1 Overview of Market Research Methodology	10
1.2.2 Market Assumption	11
1.2.3 Secondary Data	11
1.2.4 Primary Data	11
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of Asia Pacific Market by Service	41
3.1 Market Overview by Service	41
3.2 CRO for Pre-clinical Development	43
3.3 CRO for Phase I Trials	44
3.4 CRO for Phase II Trials	45
3.5 CRO for Phase III Trials	46
3.6 CRO for Phase IV Trials	47
3.7 Laboratory Services	48
3.8 Consulting Services	49
3.9 Data Management Services	50
4 Segmentation of Asia Pacific Market by Therapeutic Application	51
4.1 Market Overview by Therapeutic Application	51
4.2 Infectious Diseases	53
4.3 Oncology	54
4.4 Metabolic Disorders	55
4.5 Cardiovascular Disorders	56
4.6 Central Nervous System	57
4.7 Respiratory Disorders	58
4.8 Gastrointestinal Disorders	59
4.9 Other Therapeutic Applications	60
5 Segmentation of Asia Pacific Market by End User	61
5.1 Market Overview by End User	61
5.2 Pharmaceutical & Biopharmaceutical Companies	63
5.3 Medical Device Companies	64
5.4 Academic Institutes	65
6 Asia-Pacific Market 2019-2030 by Country	67
6.1 Overview of Asia-Pacific Market	67
6.2 Japan	70
6.3 China	73
6.4 Australia	75
6.5 India	77
6.6 South Korea	80
6.7 Rest of APAC Region	82
7 Competitive Landscape	84
7.1 Overview of Key Vendors	84
7.2 New Product Launch, Partnership, Investment, and M&A	88
7.3 Company Profiles	89
Charles River Laboratories	89
CMIC Co. Ltd	91
Covance Inc.	92
Hangzhou Tigermed Consulting Co Ltd	93
ICON Plc	94
IQVIA Holdings Inc.	95
LSK Asia Pacific Pharma Service Co Ltd	96
Novotech Pty Ltd	97
PAREXEL International Corporation	98
Pharmaceutical Product Development LLC (PPD)	99
PRA Health Sciences Inc.	100
Quanticate Ltd	101
Samsung Bioepis Co. Ltd	102
SGS SA (SGS Life Sciences)	103
Syneos Health Inc.	104
WuXi AppTec Inc.	105
8 Investing in Asia Pacific Market: Risk Assessment and Management	106
8.1 Risk Evaluation of Asia Pacific Market	106
8.2 Critical Success Factors (CSFs)	109
Related Reports and Products	112
Table 1.  Snapshot of Asia Pacific Pharmaceutical CRO Market in Balanced Perspective, 2019-2030	17
Table 2. Growth Rate of World Real GDP, 2017-2021	21
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn	27
Table 4. Worldwide Total Number of Registered Clinical Trials	29
Table 5.  Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical CRO Market	33
Table 6. Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, $ bn	41
Table 7. Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	51
Table 8. Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, $ bn	61
Table 9. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn	68
Table 10. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn	72
Table 11. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	72
Table 12. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn	72
Table 13. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn	74
Table 14. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	74
Table 15. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn	74
Table 16. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn	76
Table 17. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	76
Table 18. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn	76
Table 19. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn	79
Table 20. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	79
Table 21. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn	79
Table 22. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn	81
Table 23. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn	81
Table 24. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn	81
Table 25. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn	83
Table 26. Breakdown of Asia Pacific Market by Key Vendor, 2019, %	86
Table 27. Charles River Laboratories: Company Snapshot	89
Table 28. Charles River Laboratories: Business Segmentation	89
Table 29. Charles River Laboratories: Product Portfolio	90
Table 30. Charles River Laboratories: Revenue, 2016-2018, $ bn	90
Table 31. Charles River Laboratories: Recent Developments	90
Table 32.  Risk Evaluation for Investing in Asia Pacific Market, 2019-2030	107
Table 33. Critical Success Factors and Key Takeaways	110

Figure 1. Research Method Flow Chart	10
Figure 2. Breakdown of Primary Research	12
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	16
Figure 5. Asia Pacific Pharmaceutical CRO Market, 2019-2030, $ bn	19
Figure 6. Impact of COVID-19 on Business	23
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical CRO Market	25
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical CRO Market	30
Figure 9. Investment Opportunity Analysis	34
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical CRO Market	37
Figure 11. Breakdown of Asia Pacific Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue	42
Figure 12. Asia Pacific Addressable Market Cap in 2020-2030 by Service, Value ($ bn) and Share (%)	42
Figure 13. Asia Pacific Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn	43
Figure 14. Asia Pacific Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn	44
Figure 15. Asia Pacific Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn	45
Figure 16. Asia Pacific Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn	46
Figure 17. Asia Pacific Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn	47
Figure 18. Asia Pacific Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn	48
Figure 19. Asia Pacific Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn	49
Figure 20. Asia Pacific Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn	50
Figure 21. Breakdown of Asia Pacific Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue	52
Figure 22. Asia Pacific Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%)	52
Figure 23. Asia Pacific Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn	53
Figure 24. Asia Pacific Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn	54
Figure 25. Asia Pacific Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn	55
Figure 26. Asia Pacific Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn	56
Figure 27. Asia Pacific Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn	57
Figure 28. Asia Pacific Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn	58
Figure 29. Asia Pacific Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn	59
Figure 30. Asia Pacific Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn	60
Figure 31. Breakdown of Asia Pacific Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue	62
Figure 32. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ bn) and Share (%)	62
Figure 33. Asia Pacific Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn	63
Figure 34. Asia Pacific Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn	64
Figure 35. Asia Pacific Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn	65
Figure 36. Breakdown of APAC Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue	68
Figure 37. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)	69
Figure 38.  Pharmaceutical CRO Market in Japan, 2019-2030, $ bn	71
Figure 39.  Pharmaceutical CRO Market in China, 2019-2030, $ bn	73
Figure 40.  Pharmaceutical CRO Market in Australia, 2019-2030, $ bn	75
Figure 41.  Pharmaceutical CRO Market in India, 2019-2030, $ bn	77
Figure 42.  Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn	80
Figure 43.  Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn	82
Figure 44. Growth Stage of Asia Pacific Pharmaceutical CRO Industry over the Forecast Period	84
Companies Included in Reports:
Key Players (this may not be a complete list and extra companies can be added upon request): 
Charles River Laboratories	
CMIC Co. Ltd	
Covance Inc.	
Hangzhou Tigermed Consulting Co Ltd	
ICON Plc	
IQVIA Holdings Inc.	
LSK Global Pharma Service Co Ltd	
Novotech Pty Ltd	
PAREXEL International Corporation	
Pharmaceutical Product Development LLC (PPD)	
PRA Health Sciences Inc.	
Quanticate Ltd	
Samsung Bioepis Co. Ltd	
SGS SA (SGS Life Sciences)	
Syneos Health Inc.	
WuXi AppTec Inc.
Frequently Asked Questions
Asia Pacific Pharmaceutical Contract Research Organization Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Asia Pacific Pharmaceutical Contract Research Organization Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Asia Pacific Pharmaceutical Contract Research Organization Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports